Microvascular diabetic complications are the most common causes of morbidity and mortality of patients with type  disease. Diabetic nephropathy is becoming the single most common cause of end stage renal failure, while diabetic retinopathy is the most common cause of blindness in working-age population. Th e main aim of the study was to evaluate the progression of late microvascular complications in type  diabetic patients treated by conventional or intensifi ed insulin regimen over the period of  years. We selected a random sample of  patients, including  males and  females, aged
Introduction
Seriousness of metabolic disorder in diabetes mellitus is mostly exposed in the form of development of late microvascular and macrovascular complications. Diabetic nephropathy is becoming the most frequent cause of end-stage renal failure, and currently, in Europe and the USA, - of those requiring renal replacement therapy, dialysis or transplant, suffer from diabetes (, , ) . It is also known that, in the developed countries, diabetic retinopathy is the most common cause of blindness in people aged  - years () . Prevention of onset and progression of these complications is still the most important task in comprehensive treatment of people suffering from diabetes. It requires early detection of incipient microvascular changes as well as their adequate and timely treatment (,) .
Aim
Th e main aim of this study is to evaluate the onset and progression of late microvascular complications in patients with type  disease who are treated either conventionally or by intensive insulin regimen, over the period of  years.
Material and Methods
We selected a random sample of  patients with type  diabetes mellitus, who were treated on outpatient or inpatient basis at the Department of Diabetes. Patients with non-diabetic renal diseases, those who manifest renal nephropathy or those with advanced form of diabetic retinopathy were excluded. Also, those with the signs of other autoimmune diseases and liver disease were excluded from the study sample. The study was designed on the principle "intention to treat" and baseline characteristics of subjects at the beginning of the study are presented in Table  . All the patients had their fasting and postprandial blood glucose, glycosylated haemoglobin (HbAc), -hour proteinuria, blood pressure, body height and weight measured and body mass index calculated. Blood glucose levels were determined in venous blood by glucoso-oxidase method. Glycosylated Hb was also measured from the venous sample, with micro column test by chromatography method, using reagents donated by the company Bio-Rad, Milan, Italy. Body weight, height and blood pressure were measured by validated instruments, Secca  scale, Secca  statometer, and calibrated sphygmomanometer, Reister /, Diplomat according to the CINDI protocol () .  -hour proteinuria was measured by precipitation method with perchlorine acid followed by quantitative spectrophotometric reaction according to Gornall (Biuret reaction). All subjects had their eye fundus examined by direct and indirect ophtalmoscopy.
STATISTICAL ANALYSIS Data were expressed as mean values with standard deviation as a variability measure or proportions expressed as percentages. Diff erences between mean values in two periods were assessed using paired Student's t-test and were considered signifi cant at the level of p < .. Differences between proportions were analyzed by X test.
Results
In  years interval signifi cant increase in glycosylated Hb values (HbAc), fasting and postprandial blood glucose levels, systolic and diastolic blood pressure values, as well as body mass index values were noted (Table ) . However, the proportion of patients with higher levels of blood pressure (SBP ≥  mmHg, DKP ≥mHg) was not signifi cantly increased as well as the proportion of those who were overweight (BMI ≥  kg/m ) ( Table ) . Th e total number of those who developed mild retinal changes was not signifi cant but signifi cant proportion of proliferative changes was noted in the total sample (Table ). However, development of retinopathy was significantly more frequent in the group under conventional insulin regimen (p=.) ( Table ) , while signifi cant progression was not noted in the proportion of subjects under intensifi ed insulin regimen (p=.) ( Table ) . We observed signifi cant increase in the mean values of urinary proteins (p<.), as well as larger proportion of subjects with values higher than  mg/  h (p=.), as well as the percentage of those with values higher than  mg/ h (p=.) ( Table  ). An increase in the mean uroproteins was signifi cantly higher in both groups, although the increment observed in the intensifi ed insulin group was less pronounced ( Table , Table  ).
Discussion
Prevention of the development and early detection of the late microvascular complications is a priority in the treatment of people suff ering from type  diabetes mellitus. Opinions on the mode of treatment have significantly changed since , after the presentation of the results of the prospective, randomized Diabetes Control and Complication Trial (DCCT), which clearly showed that intensifi ed treatment signifi cantly delayed progression of the late microvascular changes () . In our study relatively higher proportion of participants was under conventional than under intensifi ed insulin treatment (Table ) . It is indicative that the former group had more signifi cant increase of proteinuria (p<.), while the increase in the latter group was less expressed (p=.). Progression of retinopathy was also signifi cant in the fi rst group (p=.), which was not the case in the second, intensively treated group (p=.) although the trend of increase was clearly observed. It is well documented that incipient nephropathy is the marker of the development of progressive renal disease and that initial, timely treatment requires administra-
